{"id":"istalol-and-optive","safety":{"commonSideEffects":[{"rate":null,"effect":"Ocular irritation or stinging (Istalol)"},{"rate":null,"effect":"Blurred vision (Istalol)"},{"rate":null,"effect":"Temporary blurred vision (Optive)"},{"rate":null,"effect":"Eye discomfort (Optive)"}]},"_chembl":{"chemblId":"CHEMBL1628401","moleculeType":"Small molecule","molecularWeight":"657.81"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Istalol (timolol) works as a non-selective beta-adrenergic antagonist that inhibits aqueous humor secretion in the eye, thereby lowering intraocular pressure in glaucoma and ocular hypertension. Optive is a combination artificial tear formulation containing carboxymethylcellulose and glycerin that lubricates and protects the ocular surface, commonly used for dry eye syndrome. These are distinct products with different mechanisms targeting different ocular conditions.","oneSentence":"Istalol is a beta-blocker that reduces intraocular pressure by decreasing aqueous humor production, while Optive is a lubricating eye drop that provides ocular surface hydration and protection.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:50:25.735Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Glaucoma and ocular hypertension (Istalol)"},{"name":"Dry eye syndrome (Optive)"}]},"trialDetails":[{"nctId":"NCT00698945","phase":"PHASE4","title":"Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)","status":"COMPLETED","sponsor":"Bp Consulting, Inc","startDate":"2008-06","conditions":"Ocular Hypertension, Open-Angle Glaucoma","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Istalol and Optive","genericName":"Istalol and Optive","companyName":"Bp Consulting, Inc","companyId":"bp-consulting-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Istalol is a beta-blocker that reduces intraocular pressure by decreasing aqueous humor production, while Optive is a lubricating eye drop that provides ocular surface hydration and protection. Used for Glaucoma and ocular hypertension (Istalol), Dry eye syndrome (Optive).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}